Substance profile
Erythromycin A Oxime
Erythromycin A Oxime is a chemical substance with the molecular formula C37H68N2O13.
01 · Identification
What Erythromycin A Oxime is
Erythromycin A Oxime is a chemical substance with the molecular formula C37H68N2O13. Its molecular formula is C37H68N2O13 and its molecular weight is 748.9 g/mol.
02 · Identifiers
Erythromycin A Oxime identifiers and molecular data
Erythromycin A Oxime CAS number and EC number
Erythromycin A Oxime molecular formula and molecular weight
Other names for Erythromycin A Oxime
- erythromycin A9-oxime (E)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-.sc.d.sc.-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
03 · GHS classification
Erythromycin A Oxime hazard classification
Harmonised classification under CLP Annex VI. This is the legally binding classification in the EU; other jurisdictions may differ.
Erythromycin A Oxime pictograms and signal word
Erythromycin A Oxime hazard class and category
| Hazard class | Category | From code | Pictogram |
|---|---|---|---|
| Hazardous to the aquatic environment - chronic GHS chapter 4.1 | Category 2 | H411 | GHS09 |
Erythromycin A Oxime hazard statements (H-codes)
| Code | Hazard statement |
|---|---|
| H411 | Toxic to aquatic life with long lasting effects. |
This page lists only the codes assigned to Erythromycin A Oxime. The full reference lives on the hazard statements hub, the precautionary statements hub and the GHS pictograms hub.
Safety Data Sheet
Getting an SDS for Erythromycin A Oxime
A Safety Data Sheet is written for a product, not for a substance: the supplier of the grade you actually buy issues it, so two suppliers of Erythromycin A Oxime issue two different sheets. That is why there is no single authoritative SDS for a substance to download — what there is, is the job of collecting the sheets for the products you hold and keeping them current as suppliers revise them.
04 · Precautionary statements
Erythromycin A Oxime precautionary statements
CLP Annex VI assigns 3 precautionary statements to Erythromycin A Oxime. They are grouped the way a label groups them: what to do before handling, what to do when something has already happened, how to store it and how to dispose of it.
Prevention
What to do before and during handling so the hazard never happens.
Disposal
What has to happen to the contents and the empty container.
Reading the notation. … is a blank the supplier fills in — not a truncated sentence.· [square brackets] mark a part printed only when it applies.
05 · Names in the regulation
Erythromycin A Oxime name in 23 EU languages
CLP Annex VI Part 3 is published in every language edition of the regulation, and the identification column is written out in each of them. Nothing below is translated by us: each line is the name as that edition prints it. Under Art. 18(2) the substance name from Annex VI is a lawful product identifier, so this is the wording to put on a label going to that market — and where the cell lists several designations, any one of them qualifies.
| Language | Name in CLP Annex VI Part 3 |
|---|---|
| Bulgarian български | еритромицин А9-оксим (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-дидеокси-3- C -метил-3- O -метил-α-L-рибохексопиранозил)окси]-14-етил-7,12,13-трихидрокси-3,5,7,9,11,13-хексаметил-6-((3,4,6-тридеокси-3-(диметиламино-β-d-ксилохексопиранозил)окси)оксациклотетрадекан-2-она-10-оксим (E) |
| Spanish español | Eritromicina A9-oxima (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-didesoxi-3- C -metil-3- O -metil-α-L-ribo-hexopiranosil)oxi)-14-etil-7,12,13-trihidroxi-3,5,7,9,11,13-hexametil-6-((3,4,6-tridesoxi-3-dimetilamino-β-d-xilohexapiranosil)oxi)oxaciclotetradecan-2-ona-10-oxima (E) |
| Czech čeština | erythromycin A9-( E )-oxim (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-[(2,6-didesoxy-3- C -methyl-3- O -methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-{[3,4,6-tridesoxy-3-(dimethylamino)-β-D-xylo-hexapyranosyl]oxy}-1-oxacyklotetradekan-2-10-dion-( E )-10-oxim |
| Danish dansk | erythromycin A9-oxim ( E ) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6,-dideoxy-3- C- methyl-3- O- methyl-α- L -ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-dimethylamino-β-D-xylohexapyranosyl)oxy)oxacyclotetradecan-2-on-10-oxim (E) |
| German Deutsch | Erythromycin A9-oxim (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-didesoxy-3-C-methyl-3- O -methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxim (E) |
| Estonian eesti | erütromütsiini A9-oksiim ( E ) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-didesoksü-3- C -metüül-3- O -metüül-α-L-riboheksopüranosüül)oksü)-14-etüül-7,12,13-trihüdroksü-3,5,7,9,11,13-heksametüül-6-((3,4,6-tridesoksü-3-dimetüülamino-β-d-ksüloheksapüranosüül)oksü)oksatsüklotetradekaan-2,10-dioon-10-oksiim ( E ) |
| Greek ελληνικά | 9-οξίμη της ερυθρομυκίνης A (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-διδεσοξυ-3- C -μεθυλο-3- O -μεθυλο-α- L -ριβο-εξοσπειρανοσυλ)οξυ)-14-αιθυλο-7,12,13-τριυδροξυ-3,5,7,9,11,13-εξαμεθυλο-6-((3,4,6-τριδεσοξυ-3-διμεθυλαμινο-β-d-ξυλοεξασπειρανοσυλ)οξυ)οξακυκλοδεκατετραν-2-ονα-10-οξίμη (E) |
| English English | erythromycin A9-oxime (E) (3 R , 4 S , 5 S , 6 R , 7 R , 9 R , 11 R ,12 R , 13 S , 14 R )-4-((2,6-didesoxy-3- C -methyl-3- O -methyl-α- L -ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) |
| French français | 9-oxime d'érythromycine A (E) 3 R , 4 S , 5 S , 6 R , 7 R , 9 R , 11 R ,12 R , 13 S , 14 R )-4-((2,6-didésoxy-3- C -méthyl-3- O -méthyl-α- L -ribo-hexopiranosyl)oxy)-14-éthyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexaméthyl-6-((3,4,6-tridésoxy-3-diméthylamino-β-d-xylohexapiranosyl)oxy)oxacyclotétradécan-2-ona-10-oxime (E) |
| Croatian hrvatski | eritromicin A9-oksim (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-didezoksi-3- C -metil-3- O -metil-α-L-ribo-heksopiranozil)oksi)-14-etil-7,12,13-trihidroksi-3,5,7,9,11,13-heksametil-6-((3,4,6-tridezoksi-3-dimetilamino-β-D-ksiloheksapiranozil)oksi)oksaciklotetradekan-2-on-10-oksim (E) |
| Italian italiano | eritromicina A9-ossima (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6,-didesossi-3-C-metil-3-O-metil-α-L-ribo-esopiranosil)ossi)-14-etil-7,12,13-triidrossi-3,5,7,9,11,13-esametil-6-((3,4,6-tridesossi-3-dimetilammino-β-D-siloesapiranosil)ossi)ossaciclotetradecan-2-ona-10-ossima (E) |
| Latvian latviešu | eritromicīna A9-oksīms (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6,-didezoksi-3- C -metil-3- O -metil-α- L -ribo-heksopiranozil)oksi)-14-etil-7,12,13-trihidroksi-3,5,7,9,11,13-heksametil-6-((3,4,6-tridezoksi-3-dimetilamino-β- d -ksiloheksapiranozil)oksi)oksaciklotetradekān-2-on-10-oksīms (E) |
| Lithuanian lietuvių | eritromicino A9 oksimas (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6,-didezoksi-3- C -metil-3- O -metil-α- L -riboheksopiranozil)oksi)-14-etil-7,12,13-trihidroksi-3,5,7,9,11,13-heksametil-6-((3,4,6-tridezoksi-3-dimetilamino-β-d-ksiloheksapiranozil)oksi)oksaciklotetradekan-2-ona-10-oksimas (E) |
| Hungarian magyar | eritromicin A9-oxim (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6,-didezoxi-3-C-metil-3- O -metil-α-L-ribo-hexopiranozil)oxi)-14-etil-7,12,13-trihidroxi-3,5,7,9,11,13-hexametil-6-((3,4,6-tridezoxi-3-dimetilamino-β-D-xilohexapiranozil)oxi)oxaciklotetradekán-2-ona-10-oxim (E) |
| Maltese Malti | A9-ossima tal-eritromiċina (E) (3 R , 4 S , 5 S , 6 R , 7 R , 9 R , 11 R ,12 R , 13 S , 14 R )-4-((2,6-didesossi-3- C -metil-3- O -metil-α- L -ribo-eżopiranosil)ossi)-14-etil-7,12,13-triidrossi-3,5,7,9,11,13-eżametil-6-((3,4,6-tridesossi-3-dimetilammino-β-d-ksiloeżapiranosil)ossi)ossaċiklotetradekan-2-ona-10-ossima (E) |
| Dutch Nederlands | erytromycine A9-oxim (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-didesoxy-3- C -methyl-3- O -methyl-α- L -ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecaan-2-on-10-oxim (E) |
| Polish polski | A9-oksym erytromycyny(E) (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6,-didezoksy-3-C-metylo-3-O-metylo-α-L-rybo-heksopiranozylo)oksy)-14-etylo-7,12,13-trihydroksy-3,5,7,9,11,13-heksametylo-6-((3,4,6-tridezoksy-3-dimetyloamino-β-D-ksyloheksapiranozylo)oksy)oksacyklotetradekan-2-ono-10-oksym (E) |
| Portuguese português | 9-oxima de eritromicina A ( E ) (10-oxima de (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6,-didesoxi-3- C -metil-3- O -metil-α-L-ribo-hexopiranosil)oxi)-14-etil-7,12,13-tri-hidroxi-3,5,7,9,11,13-hexametil-6-((3,4,6-tridesoxi-3-dimetilamino- β -D-xilo-hexapiranosil)oxi)oxaciclotetradecan-2-ona ( E ) |
| Romanian română | eritromicină A9-oximă (E) (3 R , 4 S , 5 S , 6 R , 7 R , 9 R , 11 R ,12 R , 13 S , 14 R )-4-((2,6,-didezoxi-3- C -metil-3- O -metil-α- L -ribo-hexopiranosil)oxi)-14-etil-7,12,13-trihidroxi-3,5,7,9,11,13-hexametil-6-((3,4,6-tridezoxi-3-dimetilamino-β-D-xilohexapiranosil)oxi)oxaciclotetradecan-2-onă-10-oximă (E) |
| Slovak slovenčina | erytromycín A9-oxím (E) (3R,4S,5S,6R,7R,9R,10E,11R,12R,13S,14R)-14-etyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexametyl-4-(3-C-metyl-3-O-metyl-2,6-dideoxy-α-L-ribo-hexopyranozyloxy)-6-[3-(dimetylamino)-3,4,6-trideoxy-β-D-xylo-hexapyranozyloxy]-1-oxacyklotetradekán-2,10-dión-10-oxím (E) |
| Slovenian slovenščina | eritromicin A9-oksim (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6,-didezoksi-3- C -metil-3- O -metil-α- L -ribo-heksopiranozil)oksi)-14-etil-7,12,13-trihidroksi-3,5,7,9,11,13-heksametil-6-((3,4,6-tridezoksi-3-dimetilamino-β-d-ksiloheksapiranozil)oksi)oksaciklotetradekan-2-ona-10-oksim (E) |
| Finnish suomi | erytromysiini-A9-oksiimi (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6,-didesoksi-3- C -metyyli-3- O -metyyli-α- L -ribo-heksopyranosyyli)oksi)-14-etyyli-7,12,13-trihydroksi-3,5,7,9,11,13-heksametyyli-6-((3,4,6-tridesoksi-3-dimetyyliamino-β-D-ksyloheksapyranosyyli)oksi)oksasyklotetradekan-2-ona-10-oksiimi (E) |
| Swedish svenska | erytromycin A9-oxim (E) (3 R , 4 S , 5 S , 6 R , 7 R , 9 R , 11 R , 12 R , 13 S , 14 R )-4-((2,6-didesoxi-3- C -metyl-3- O -metyl-α- L -ribohexopyranosyl)oxi)-14-etyl-7,12,13-trihydroxi-3,5,7,9,11,13-hexametyl-6-((3,4,6-tridesoxi-3-dimetylamino-β-d-xylohexapyranosyl)oxi)oxacyklotetradekan-2-ona-10-oxim (E) |
All 23 language editions of Annex VI carry this entry. Irish is the twenty-fourth official EU language and has no line here for a different reason: no consolidated CLP text has ever been published in Irish, so there is no Irish edition of Annex VI to quote a name from. Source: consolidated CLP, CELEX 02008R1272, language editions. © European Union, https://eur-lex.europa.eu — only the electronic Official Journal of the European Union is authentic.
06 · Label elements
Erythromycin A Oxime GHS label elements
Everything CLP Annex VI fixes for Erythromycin A Oxime, laid out the way it appears on a label. The greyed lines are the parts only the supplier can fill in.
Erythromycin A Oxime
- Toxic to aquatic life with long lasting effects.
- Avoid release to the environment.
- Collect spillage.
- Dispose of contents/container to …
Supplier name, address and telephone number· Product identifier·Nominal quantity
Need this as an actual label? Open Erythromycin A Oxime in the GHS label constructor →
07 · Questions
Erythromycin A Oxime — frequently asked questions
What is the CAS number of Erythromycin A Oxime?
The CAS number of Erythromycin A Oxime is 13127-18-9. Its EC number is 437-070-0.
What is the chemical formula of Erythromycin A Oxime?
The molecular formula of Erythromycin A Oxime is C37H68N2O13 and its molecular weight is 748.9 g/mol.
What does a Erythromycin A Oxime label have to show?
Under CLP Annex VI the label for Erythromycin A Oxime carries the pictogram Environment.
Is Erythromycin A Oxime flammable?
CLP Annex VI assigns Erythromycin A Oxime no flammability hazard class. That is not a statement that it cannot burn: the harmonised list only records the hazards that were assessed for it.
Is Erythromycin A Oxime a carcinogen?
CLP Annex VI records no harmonised carcinogenicity classification for Erythromycin A Oxime. Annex VI is a list of agreed classifications, not a list of substances found safe, so this is an absence of a classification rather than a clean bill of health.
Nearby
Substances next to Erythromycin A Oxime
Keep going: substances starting with E, or search the whole database by name, CAS number, pictogram or signal word.